Journal for ImmunoTherapy of Cancer (Nov 2023)
1205 Surmounting conventional cell therapy limitations via in situ CAR therapy using oRNA™ lipid nanoparticles
- Thomas Lee,
- Thomas Barnes,
- Robert Mabry,
- Ashley Wong,
- Chris Wright,
- David Soto,
- Kevin Kauffman,
- Amy Becker,
- Alex Wesselhoeft,
- Allen Horhata,
- Akinola Emmanuel,
- Akshi Thakkar,
- Ramya Elangovan,
- Magnolia Chinn,
- Sharmistha Kundu,
- Kristen Ott,
- Trent Stevens,
- Yessica Wiryawan,
- Ian Langer,
- Rahul Vungutur,
- Corey Ciullo,
- Nelson Chau,
- Renee Wright-Michaud,
- Meghan Richardson,
- Jui Dutta-Simmons,
- Rena Schindler,
- Junghoon Yang,
- Paisley Haskell
Affiliations
- Thomas Lee
- 2 Northern Region Endoscopy Group (NREG), Newcastle, UK
- Thomas Barnes
- 1Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK
- Robert Mabry
- Orna Therapeutics, Cambridge, MA, USA
- Ashley Wong
- Department of Clinical Oncology, Prince of Wales Hospital, New Territories, Hong Kong
- Chris Wright
- 2ADMEM
- David Soto
- SQZ Biotechnologies, Watertown, MA, USA
- Kevin Kauffman
- Orna Therapeutics, Cambridge, MA, USA
- Amy Becker
- Orna Therapeutics, Cambridge, MA, USA
- Alex Wesselhoeft
- Orna Therapeutics, Cambridge, MA, USA
- Allen Horhata
- Orna Therapeutics, Cambridge, MA, USA
- Akinola Emmanuel
- Orna Therapeutics, Cambridge, MA, USA
- Akshi Thakkar
- Orna Therapeutics, Cambridge, MA, USA
- Ramya Elangovan
- Orna Therapeutics, Cambridge, MA, USA
- Magnolia Chinn
- Orna Therapeutics, Cambridge, MA, USA
- Sharmistha Kundu
- Orna Therapeutics, Cambridge, MA, USA
- Kristen Ott
- Orna Therapeutics, Cambridge, MA, USA
- Trent Stevens
- Orna Therapeutics, Cambridge, MA, USA
- Yessica Wiryawan
- Orna Therapeutics, Cambridge, MA, USA
- Ian Langer
- Orna Therapeutics, Cambridge, MA, USA
- Rahul Vungutur
- Orna Therapeutics, Cambridge, MA, USA
- Corey Ciullo
- Orna Therapeutics, Cambridge, MA, USA
- Nelson Chau
- Orna Therapeutics, Cambridge, MA, USA
- Renee Wright-Michaud
- Orna Therapeutics, Cambridge, MA, USA
- Meghan Richardson
- Orna Therapeutics, Cambridge, MA, USA
- Jui Dutta-Simmons
- Orna Therapeutics, Cambridge, MA, USA
- Rena Schindler
- Orna Therapeutics, Cambridge, MA, USA
- Junghoon Yang
- Orna Therapeutics, Cambridge, MA, USA
- Paisley Haskell
- Orna Therapeutics, Cambridge, MA, USA
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.1205
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.
